GEN29d
Eczema Drugs Could Counter Ovarian Cancer’s IL-4-Based Immunotherapy Resistance
The authors further stated, “Perturb-map recapitulated tumor heterogeneity and revealed that interleukin ... IL-4 receptor-blocking drugs in mice with aggressive metastatic ovarian cancer ...
Promising Clinical Outcomes and Buy Rating for Medicenna Therapeutics’ MDNA11
In a report released today, David Martin PhD from Bloom Burton maintained a Buy rating on Medicenna Therapeutics Corp (MDNA – Research ...
Business Insider3d
Medicenna Presents Preclinical Data on MDNA11 and Bizaxofusp at the 2024 Annual Meeting of the Society for Neuro-Oncology (SNO)
Bizaxofusp acts by targeted delivery of a potent toxin to several types of aggressive cancers that express the interleukin-4 receptor (IL-4R), such as GBM ... such as regulatory T cells (Tregs), which ...
News Medical28d
New therapeutic target overcomes ovarian cancer immunotherapy resistance
The researchers found that ovarian cancer cells produce a molecule called Interleukin-4 (IL-4), which ... tested a combination of anti-PD-1 and IL-4 receptor-blocking drugs in mice with aggressive ...
Science Daily1mon
Study identifies how ovarian cancer protects itself, paves way for improved immunotherapy approach
They found that ovarian cancer cells produce a molecule called Interleukin-4 (IL-4), which ... then tested a combination of anti-PD-1 and IL-4 receptor-blocking drugs in mice with aggressive ...
Medical Xpress1mon
Study finds eczema-linked protein helps ovarian cancer survive, suggesting potential for skin drug-based treatment
The researchers found that ovarian cancer cells produce a molecule called Interleukin-4 (IL-4), which ... tested a combination of anti-PD-1 and IL-4 receptor-blocking drugs in mice with aggressive ...